These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 17980454

  • 1. Cell transfer regimens in patients with highly advanced surgically unresectable non-small cell lung cancer: significantly improved overall survival in patients with lower levels of serum immunosuppressive acidic protein.
    Ebina T, Fujimiya Y.
    Lung Cancer; 2008 May; 60(2):246-51. PubMed ID: 17980454
    [Abstract] [Full Text] [Related]

  • 2. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S, Nagato K, Kunii N, Yamamoto H, Yamasaki K, Okita K, Hanaoka H, Shimizu N, Suzuki M, Yoshino I, Taniguchi M, Fujisawa T, Nakayama T.
    J Immunol; 2009 Feb 15; 182(4):2492-501. PubMed ID: 19201905
    [Abstract] [Full Text] [Related]

  • 3. [Non-small cell lung cancer--immunocell BAK (BRM activated killer) therapy].
    Ebina T.
    Nihon Rinsho; 2006 Jul 15; 64(7):1339-44. PubMed ID: 16838654
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb 15; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 5. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 6. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, Shimizu N, Horiguchi S, Okamoto Y, Fujii S, Taniguchi M, Fujisawa T, Nakayama T.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6079-86. PubMed ID: 17028247
    [Abstract] [Full Text] [Related]

  • 7. Adoptive cellular immunotherapy for non-small cell lung cancer: a pilot study.
    Chan B, Lee W, Hu CX, Ng P, Li KW, Lo G, Ho G, Yeung DW, Woo D.
    Cytotherapy; 2003 Oct 15; 5(1):46-54. PubMed ID: 12745587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C, Jiang J, Shi L, Xu N.
    Anticancer Res; 2008 Oct 15; 28(6B):3997-4002. PubMed ID: 19192663
    [Abstract] [Full Text] [Related]

  • 10. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S, Kayi Cangir A, Ozturk S, Dizbay Sak S, Akal M, Akay H.
    Tuberk Toraks; 2008 Oct 15; 56(3):251-6. PubMed ID: 18932025
    [Abstract] [Full Text] [Related]

  • 11. Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer.
    Sirera R, Gil M, Blasco A, Cabrera A, Safont MJ, Iranzo V, Cayuela D, Rosell R, Camps C.
    Lung Cancer; 2008 Jul 15; 61(1):104-8. PubMed ID: 18243403
    [Abstract] [Full Text] [Related]

  • 12. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M, Crisan E, Radut M, Tarlea A, Median D, Alexandru A, Vremes G, Gal C.
    Lung Cancer; 2009 Feb 15; 63(2):271-6. PubMed ID: 18565617
    [Abstract] [Full Text] [Related]

  • 13. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008 Feb 15; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A, Kaya A, Yetkin O, Poyraz B, Savaş I, Numanoğlu N, Savaş H.
    Tuberk Toraks; 2008 Feb 15; 56(4):390-5. PubMed ID: 19123074
    [Abstract] [Full Text] [Related]

  • 15. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC.
    Thorax; 2009 Mar 15; 64(3):192-6. PubMed ID: 19252018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.
    Wibmer T, Kropf C, Merk T, Schumann C, Hombach V, Krüger S.
    Lung Cancer; 2008 May 15; 60(2):231-9. PubMed ID: 18006111
    [Abstract] [Full Text] [Related]

  • 19. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
    Panagopoulos ND, Karakantza M, Koletsis E, Apostolakis E, Sakellaropoulos GC, Filos KS, Eleni T, Dougenis D.
    Lung Cancer; 2008 Nov 15; 62(2):273-80. PubMed ID: 18430486
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
    Peschel C, Hartmann JT, Schmittel A, Bokemeyer C, Schneller F, Keilholz U, Buchheidt D, Millan S, Izquierdo MA, Hofheinz RD.
    Lung Cancer; 2008 Jun 15; 60(3):374-80. PubMed ID: 18054408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.